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1. Introduction 
The International Pharmaceutical Excipients Council (IPEC) define an excipient as any substance other 
than the active drug or prodrug that is included in the manufacturing process or is contained in a finished 
pharmaceutical dosage form [1]. Drug dosage forms are rather complex systems containing many components in 
addition to active pharmaceutical ingredients (APIs). Formulators apply practical understanding of pharmaceutical 
excipients to develop optimal, robust formulations and the appropriate manufacturing processes. Excipients facilitate 
formulation design and perform a wide range of functions to obtain desired properties for the finished drug 
product[2]. Herbal medicines may contain excipients in addition to the active ingredients. Excipients can help ease 
manufacturing procedure hence formula including the amount of excipients should be described in details. Other 
goals such as controlled release have been reported to be achievable with the inclusion of suitable polymers [3]. The 
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Abstract 
Objective: This study investigates the effect of selected excipients on microcapsules properties of seeds 
extracts of Garcinia kola (GK) and Hunteria umbellata (HU).  
Method: Extracts from macerated dried powdered seeds were microencapsulated with chitosan-alginate 
including either talc, HPMCAS, Eudragit
®
RLPO or Eudragit
®
L100 up to 25% in the core. Microcapsules 
were characterized using differential scanning calorimertry (DSC), X-ray diffractometry (XRD), Fourier 
transform infrared spectroscopy (FTIR) and In vitro release.  
Results: DSC, XRD and FTIR showed no change in crystalline properties and functional groups of 
microcapsules and excipients in the formulations. In vitro extract release showed retardation of extract 
release in acid medium after 2 h and between 80 to 100% at pH 6.8. Generally, the microcapsules fitted 
more closely to first order model than the other models. 
Conclusion: Inclusion of these excipients did not impart negatively in interaction and release profile on 
microcapsules containing GK and HU aqueous extracts and can therefore be added to facilitate microcapsule 
production and enhance dosage form performance. 
Keywords: Excipients, Garcinia kola, Hunteria umbellata, talc, HPMCAS, polymethacrylic acid derivatives, 
polymers 
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granulated herb is first mixed or coated with an adjuvant or mixture of adjuvants selected from the group consisting 
of polymers such as polyvinyl, polyethylenes, cellulose, polyacrylate, fats, waxes and sugars, and then processed 
into a form selected from the group of microcapsules and pellets. The microcapsules or pellets are filled into hard 
gelatin capsules.  
Some polymers and pigments used as excipients in drug formulation include chitosan, polymetacrylic acid 
derivatives, the cellulosics and talc. Chitosan is deacetylated chitin obtained from the shell of crustaceans. Its film 
forming abilities lend itself well as a coating agent for conventional solid dosage forms such as tablets [4]. 
Furthermore, its gel and matrix-forming abilities make it useful for solid dosage forms, such as granules and 
microparticles.  
There are several ranges of polymers derived from metacrylates and metacrylic acid co-polymers 
depending on the method of production and their intended use. These polymers have wide range of applications 
including their use as filler for embedding active substances in the construction of matrix structures in depot or 
retard formulations. Eudragit RL has a low content of quaternary ammonium groups that are present as salts and 
give rise to the permeability of the lacquer films. They afford water – insoluble, but permeable film coatings [5]. 
 Hydroxylpropyl methylcellulose acetate succinate (HPMCAS) is a white powder with an average particle 
size of less than 5 µm and can be dispersed readily in water. The characteristics of HPMCAS are related to its 
degree and type of substitution. The various types of HPMCAS dissolve more readily as the pH increases. HPMCAS 
has been reported to produce significant changes in the release profiles of microcapsules when it was incorporated in 
the microcapsule by coating the microcapsule membrane as well as blending it with the capsule core polymer in 
varying ratios. In fact, at pH 1.2, the modified microcapsules retained up to 60 % of the encapsulated drug after 24 
hours [6].  
 Talc is a water insoluble mineral composed of hydrated magnesium silicate. It is the widely used substance 
known as talcum powder hence, the US Food and Drug Administration (FDA) considers talc (magnesium silicate) to 
be generally recognized as safe (GRAS) for use as an anti-caking agent in table salt in concentrations smaller than 2 
% [7]. Talc is used in many industries such as paper making, plastic, paint and coatings, rubber, food, electric cable, 
cosmetics, ceramics, etc. and in pharmaceuticals, it finds use as a lubricant or glidant in tablet production, in baby 
powder. The objective of this study was to investigate the modulation of aqueous seed extract release of Garcinia 
kola (GK) and Hunteria umbellata (HU) from chitosan-alginate microcapsules prepared with either talc, HPMCAS, 
the acrylate metacrylic acids derivatives. 
 
2. Materials and Methods 
2.1 Materials 
Fresh seeds of Hunteria umbellata (HU) and Garcinia kola (GK) were collected in Benin City, Nigeria 
between April and June. Chitosan was obtained from Sigma-Aldrich, Germany and Sodium alginate (Saltiagin
®
) 
was obtained from Sanofi Bio Industries, Canada. Hydroxylpropyl methylcellulose acetate succinate (HPMCAS), an 
enteric polymer is a product of Shin Etsu Chemical Co. Ltd, Japan, while Eudragit
®
 RLPO and L100 were gifts from 
Rhom Pharma Chemical Co, Germany. All other chemicals used were of reagent grade and were used without 
further purification. 
 
2.2 Methods 
The method of extraction and preparation of plant material as well as preparation and characterization of 
microcapsules have been described in the part 1 of this study [8]. 
 
2.3 Preparation of excipient - sodium alginate - plant extract solutions 
The alginate/plant extract mixture was mixed with another solution of plant extract containing 2% of either 
talc, HPMCAS, Eudragit L100 or Eudragit RLPO dispersed in it, in the ratio 3:1. (i.e., 75 ml of alginate-plant 
extract to 25 ml of excipient-plant extract). These were the highest proportions of excipients beyond which stable 
microcapsules could not form. Table 1 shows the different batches of microcapsules and their respective codes.  
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Table 1: Batch codes of microcapsules produced 
Codes Microcapsules types 
GK Garcinia kola 
BM Blank or microcapsule not containing any plant extract 
PAGKA Physical admixtures of dried GK extract and alginate powder 
GKA Microcapsules containing only alginate and GK 
GKA3T1 GK microcapsules containing alginate and talc; ratio 3:1 
GKA3H1 GK microcapsules containing alginate and HPMCAS; ratio 3:1 
GKA3R1 GK microcapsules containing alginate and Eudragit
®
 RLPO; ratio 3:1 
GKA3L1 GK microcapsules containing alginate and Eudragit
®
 L100; ratio 3:1 
HU  Hunteria umbellata 
PAHUA Physical admixtures of dried HU extract and alginate powder 
HUA Microcapsules containing only alginate and HU 
HUA3T1 HU microcapsules containing alginate and talc; ratio 3:1 
HUA3H1 HU microcapsules containing alginate and HPMCAS; ratio 3:1 
HUA3R1 HU microcapsules containing alginate and Eudragit
®
 RLPO; ratio 3:1 
HUA3L1 HU microcapsules containing alginate and Eudragit
®
 L100; ratio 3:1 
 
2.4 Dissolution studies  
In vitro release studies were carried out at pH 1.2 for 2 h and 6.8 for a further period of 10 h using the USP 
type 1 method. For each batch, microcapsules (250 mg) were placed in each dissolution basket and dipped in 500 ml 
of the dissolution medium (0.1 M HCl) maintained at 37± 0.5
o
C and then rotated at 100 revolutions per min (rpm) 
for 2 h. Following this 2 h period the basket holder was lifted and immediately transferred into another medium 
containing phosphate buffer pH 6.8 at 37 ± 0.5 
o
C and the test continued for another 10 h. Samples (5 ml) were 
collected every hour and filtered using a Whatmann No 1 filter paper. After each withdrawal, 5 ml of fresh buffer 
maintained at the same temperature was used to replenish the dissolution medium. Release of the extracts from the 
microcapsules was monitored spectrophotometrically at 292 and 280 nm for GK, and Hu, respectively [9]. The 
dissolution values of the various formulations at different time points were compared using similarity factor (f2) and 
difference factor (f1) which were calculated using Equations 1 and 2. 
F1 = {[Σ t=1
n
 |Rt-Tt|] / [Σ t=1
n 
Rt]} ×100 …. (1) 
f2 = 50×log {[1+ (1/n) Σ t=1
n
 (Rt-Tt) 
2
] 
- o.5 
×100} …. (2) 
where Rt and Tt are the cumulative percentage dissolved at each of the selected ‘n’ time points of the reference and 
test product, respectively.  
2.5 Data analysis 
All experiments were conducted in triplicate and the results expressed as mean ± standard deviation (SD). 
Statistical analysis was carried out using Microsoft Excel, version 2007. Differences between means were 
determined with one-way analysis of variance (ANOVA) at level of significance of p < 0.05. Origin lab
®
 software 
version 7.0, was used for elaboration of spectral data from FTIR, DSC and XRD. 
 
3. Results and Discussion 
3.1 Effect of inclusion of excipients on the thermal properties of microcapsules 
Figures 1 a and b show the effect of inclusion of excipients in the microcapsule core on the DSC 
thermograms of the microcapsules. There was an endothermic peak followed by a transition at 175
o
C which likely 
represents thermal decomposition. The thermogram of microcapsules containing excipients was essentially similar 
to those of the microcapsules containing only the extract or the blank microcapsules. It is apparent that the chitosan-
alginate microcapsules formed were physically stable and their thermal properties were not affected by the presence 
of the excipients added. 
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Figure 1: DSC Thermogram of GK (a) and HU (b) microcapsules modified with different excipients. Key: BM: 
Blank microcapsules; GkA or HuA:- microcapsules containing only alginate and GK or HU. A3T1 or A3H1 or 
A3R1 or A3L1:- microcapsules containing 3 parts of Alginate plus 1part of either talc (T) or HPMCAS (H) or 
Eugragit
®
RLPO or Eugragit
®
L100 (L)  
 
3.2 Effect of excipients on X-ray diffraction properties of microcapsules 
The effect of inclusion of excipients on XRD spectra is displayed in Figures 2 a, and b. Talc is crystalline 
with peaks at 6
o
 and 27
o
. Thus, crystalline properties of the blank chitosan alginate microcapsules (BM) were not 
affected by the presence of the aqueous plant extracts or the excipients. All the microcapsule formulations of the two 
plant extracts containing talc showed distinct crystalline peaks at 6
o
 and 27
o 
corresponding to that of talc. 
Furthermore, the crystalline peaks of chitosan-calcium-alginate at 31
 o 
did not shift following microcapsule 
production when the extracts and excipients were incorporated. Thus the crystalline properties were not affected by 
the presence of the plant extracts and excipients. 
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Figures 2 (a and b): X-ray powder diffractograms of excipients; (c and d) X ray powder diffractograms of 
microcapsules containing GK and HU, respectively. Key: BM: Blank microcapsules; GkA or HuA:- microcapsules 
containing only alginate and GK or HU; A3T1 or A3H1 or A3R1 or A3L1:- microcapsules containing 3 parts of 
Alginate plus 1 part of either talc (T) or HPMCAS (H) or Eugragit
®
RLPO or Eugragit
®
L100 (L)  
 
3.3 FTIR spectroscopy 
The FTIR spectra of excipients and extracts are shown in Figure 3 a, while those of microcapsules 
containing excipients are in Figures 3 b and c. With the exception of talc, the spectra revealed obvious similarities in 
the functional groups of the primary constituents of the excipients, extracts and microcapsules, with characteristic 
absorption spectra for OH stretching at wavenumber of 3400-3550 cm
-1
, and CH stretching of CH2 and CH3 at 
wavenumber of 1922 cm
-1
. There were absorption bands between 1430 and 1730 cm
-1
 as well. There was no change 
in the functional groups of the different compounds in the microcapsules before and after extract encapsulation or as 
a result of inclusion of excipients. This indicates that there was no chemical reaction between the extracts and other 
materials in the formulation. 
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Figures 3 (a, b and c): FTIR spectra of microcapsules containing Garcinia kola and Hunteria umbellata extracts 
alone and with excipients Key: GK: Garcinia kola; BM: Blank microcapsules; PA GKA: Physical admixtures of GK 
and alginate powder; GKA: microcapsules containing only alginate and GK.  T: Talc; H: HPMCAS; R: Eugragit
®
 
RLPO; L: Eudragit
®
 L100; HU: Hunteria umbellata A3T1 or A3H1 or A3R1 or A3L1: microcapsules containing 
alginate and either T or H or R or L in 3:1 ratio 
 
3.4 Release of Garcinia kola and HU extract from modified microcapsules 
The GKA and GKA3L1 microcapsules released only 23 % of their contents while the least release was 
observed from the microcapsules containing HPMCAS (20 %) after 2 h. Though chitosan has been reported not to 
prevent drug diffusion in acid medium because of its acid solubility [6], there seem to be an impediment to the 
release of the extract from the microcapsules especially as they remained intact over the 2 h period in simulated 
gastric fluid. While it was expected that the enteric polymers (Eudragit and HPMCAS) may have been responsible 
for retarding drug release in the case of the microcapsules containing them, it is not clear why the unmodified 
microcapsules also hindered drug release. G. kola is reported to contain natural gums [10] which may have played a 
role in compaction of the microcapsules and hence retarding extract diffusion out of the capsules [8]. Talc and 
Eudragit
®
RLPO containing microcapsules released over 40 % content within 2 h. it is probable that some extract 
diffused out of the microcapsules and dried around the coat during drying and this may have been responsible for the 
high amount observed in the first 2 h. Furthermore, talc and Eudragit
®
RLPO have mean larger particle sizes > 200 
µm when compared with HPMCAS and Eudragit
®
L100 (< 100 µm) [11-14]. The particles are therefore more likely 
to interfere with the chitosan/calcium-alginate matrix thus creating cracks or flaws through which drug diffusion 
were facilitated.  
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Figure 4 a and b: Release of extract from Gk (a) and Hu (b) microcapsules modified with either talc (T) or 
HPMCAS (H) or Eugragit ® RLPO or Eugragit ® L100 (L)  
 
When the microcapsules were transferred into phosphate buffer pH 6.8 after 2 h and the dissolution 
continued for another 10 h, they all demonstrated steady release of their contents. Maximum release was obtained 
from microcapsules containing talc and Eudragit
®
L100 (Figures 4 a, and b). The excipients interfered with the gel 
structure of the microcapsules and hence reduced the compactness. The unmodified microcapsules did not release all 
their content after 12 h probably because it was more compact due to the alginate and natural gums present in the 
core. When the release profiles of all the microcapsules containing excipients were compared with that of the 
unmodified microcapsules (Table 2), the similarity and difference factor data show that the two extracts behaved 
differently. In the case of GK, extract release from the unmodified microcapsules (GKA) were significantly different 
from those containing the excipients (f1 values ≥ 15, while f2 < 50) except for GKA3H1. GK extract release from 
microcapsules containing HPMCAS showed a high level of similarity with the unmodified (f2 > 50). HPMCAS is 
an enteric polymer, which did not appear to interfere with the alginate/plant extract matrix significantly [15-16]. 
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The results of the release studies on the microencapsulated extract of Hunteria are shown in Figure 4b. In 2 
h, less than 20 % of the extract was released by HUA3H1 microcapsules compared with HUA3L1 which exhibited 
33 % release within the same period. There was no significant difference (p < 0.05) between HUA, HUA3T1 and 
HUA3R1 in terms of extract release in acid medium as over 50 % was released from the microcapsules. The 
similarity and difference data between the release profiles show that the release from the HUA3L1 and HUA3H1 
microcapsules were significantly different from HUA microcapsules (f1 values > 15; f2 < 50) while HUA3T1 and 
HUA3R1 microcapsules showed a high level of similarity in release with the unmodified (f2 > 50) (Table 2). After 
10 h at pH 6.8, they all demonstrated steady extract release. Maximum release was obtained from HUA3H1 
microcapsules.  
Table 2: f1 and f2 values for dissolution profiles of GK and HU microcapsules 
Microcapsule type f1 f2 
GKA/GKA3T1 17.98 43.35 
GKA/GKA3R1 14.48 47.94 
GKA/GKA3L1 22.54 38.56 
GKA/GKA3H1 6.56 65.03 
HUA/HUA3T1 5.54 63.72 
HUA/HUA3R1 8.93 54.49 
HUA/HUA3L1 16.55 43.75 
HUA/HUA3H1 20.88 37.23 
Note: f1 values ≤ 15 indicate minor difference in dissolution rate, while f2 values > 50 indicate similarity in dissolution rate  
 
3.5 Kinetic Data Analysis 
Table 3 presents the regression coefficient (r
2
) values for the release models to which the extract release 
data were fitted. The r
2
 values were generally low with very few exceptions. The unmodified microcapsules had r
2
 
values above 0.9 for First order, and Millar and Peppas. Modulating the microcapsule core with the different 
excipients did not significantly affect r
2
 values. In this study, the movement of dosage form from the acid pH of the 
stomach to intestinal fluid was simulated. Extract diffusion from microcapsules fitted more closely to first order 
release model than the other models, thus, extract diffusion rate decreased in proportion to the amount of extract 
remaning in the microcapsule. All the formulations fitted poorly with zero order and Higuchi models. The extract 
release from most of the microscapsules displayed a diffusion controlled mechanism (n < 0.45) in Korsmeyer’s 
equation. The few exceptions were GKA, GKA3L1 and HUA3H1 in which n was greater than 0.45. The exact 
reason for this cannot be immediately explained since each batch of microcapsules varied significantly in terms of 
constituents. 
Table 3: Regression coefficient (r
2
) values for the different release models 
 Zero order First order Higuchi Millar and Peppas 
(n values in brackets) 
HUA 0.5977 0.9679 0.7529 0.9120 (0.258) 
HUA3T1 0.5819 0.9912 0.7080 0.9676 (0.213) 
HUA3R1 0.5737 0.9825 0.6852 0.9736 (0.202) 
HUA3L1 0.7626 0.9833 0.9176 0.9540 (0.368) 
HUA3H1 0.7466 0.9227 0.8600 0.8601 (0.500) 
GKA 0.8185 0.9665 0.9222 0.9225 (0.513) 
GKA3T1 0.7714 0.9930 0.9288 0.9577 (0.381) 
GKA3R1 0.7851 0.9903 0.9300 0.9560 (0.398) 
GKA3L1 0.7871 0.9593 0.9056 0.9046 (0.496) 
GKA3H1 0.8200 0.9584 0.9095 0.9123 (0.283) 
 
4. Conclusion 
 Microcapsules containing Garcinia kola and Hunteria umbellata aqueous extracts were produced 
successfully and these can serve as suitable alternative to liquids and dried powdered leaf phytoformulations. 
Inclusion of excipients had no significantly negative effect on interaction and release profile of the extracts from 
microcapsules. Hence, these excipients can be included to facilitate microcapsule production process as well as 
enhance the formulation performance.  
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